Nephrogenic systemic fibrosis - PDFSEARCH.IO - Document Search Engine

Nephrogenic systemic fibrosis
Results: 47

#	Item
11	AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Page: 2 of Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Nephrogenic systemic fibrosis Gadodiamide Magnetic resonance imaging Pentetic acid Contrast medium Gadoteridol Gadoversetamide Schering AG Chemistry Matter Gadopentetic acid
12	Microsoft Word - MH Briefing Document -Final.doc Add to Reading List Source URL: www.fda.gov Language: English Nephrogenic systemic fibrosis Nephrology Gadodiamide Gadopentetic acid Gadolinium Magnetic resonance imaging Gadobutrol Gadobenic acid Chronic kidney disease Chemistry Matter Medicine
13	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Nephrology Gadopentetic acid Gadolinium Gadodiamide Magnetic resonance imaging Pentetic acid Schering AG Gadoteridol Contrast medium Chemistry Matter Nephrogenic systemic fibrosis
14	Microsoft Word - GBCA Advisory Committee Meeting Briefing Document - Optimark - Errata.doc Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Nephrogenic systemic fibrosis Covidien Gadoversetamide Chemistry Matter Mallinckrodt Incorporated
15	[removed]Gadobutrol Statistical PREA Add to Reading List Source URL: www.fda.gov Language: English Magnetic resonance imaging Gadodiamide Medical imaging Gadopentetic acid Nephrogenic systemic fibrosis Gadoteridol Gadolinium Chemistry Medicine Matter
16	Microsoft Word - DDR letter - final with signatures[removed]mcm.doc Add to Reading List Source URL: www.fda.gov Language: English Nephrogenic systemic fibrosis Nephrology Gadodiamide Gadopentetic acid Gadolinium Magnetic resonance imaging Hepatorenal syndrome Gadoteridol Contrast medium Chemistry Matter Medicine
17	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Magnetic resonance imaging Gadopentetic acid Food and Drug Administration Nephrogenic systemic fibrosis MRI contrast agent Chemistry Matter Gadodiamide
18	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Nephrogenic systemic fibrosis Gadopentetic acid Gadolinium Magnetic resonance imaging Pentetic acid MRI contrast agent Chemistry Matter Gadodiamide
19	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Nephrology Gadolinium Magnetic resonance imaging Methadone Mallinckrodt Incorporated MRI contrast agent Chemistry Matter Nephrogenic systemic fibrosis
20	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Nephrology Gadodiamide Gadolinium Magnetic resonance imaging Gadoteridol Gadopentetic acid Renal failure MRI contrast agent Nephrogenic systemic fibrosis Chemistry Matter Medicine